SpineVision(R) announced today that it has raised more than $16 million. The Company will use approximately 80 percent of these funds to spin off its New Technologies Business Unit, creating a new wholly owned subsidiary--FlexSpine--to be headquartered in Singapore.

Investors were led by Bio*One Capital, the biomedical sciences investment arm of the Singapore Economic Development Board. Other institutional investors included Sofinnova Partners, HBM Ventures, Innoven Private Equity, and HealthCap.

INFO SOURCES

SpineVision(R)

FIRMS

SpineVision(R) is a privately owned, integrated spinal technology company focused on design, development and marketing of implants and instrumentation for spinal surgery. The Company's international headquarters are in Paris, and the Company's U.S. headquarters are located in Atlanta.

PEOPLE

Gerard Vanacker, CEO and founder of SpineVision

Swee Yeok CHU, CEO of Bio*One Capital